Skip to main content
OpenTrials
Completed

NCT Number: NCT00636831

Prophylactic Antibiotic Use in Hernioplasty

The purpose of this study is to determine whether prophylactic antibiotic use in inguinal hernioplasty are effective in prevention of infectious complication.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Nihon University School of Medicine, Department of Surgery

Tokyo, 179-0072, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary inguinal hernia
  • Elective surgery
  • Must be older than 20 years of age
  • Must not have any serious complication

Exclusion criteria

  • Incarceration
  • Recurrence
  • Drug allergy
  • Diabetes mellitus
  • Malignant diseases
  • Serious heart diseases
  • Psychological diseases
  • Pregnancy
  • Have been medicated with corticosteroids

Treatment and study plan

Antibiotic: cefazolin Sodium

Drug

1g continuous IV at 30 minutes before starting operation

Primary outcomes

  1. infectious complication

    Time frame: two year

Secondary outcomes

  1. Recurrence of inguinal hernia

    Time frame: two year

Sponsors and collaborators

Lead sponsor

Nihon University

Other

Registry information

Official study title

Prophylactic Antibiotic Use in Inguinal Hernioplasty: A Placebo-controlled, Double-blind Trial

Acronym: RCT-herniation

Important dates

Study start
2007
Primary completion
2012
Study completion
2012
First posted
Mar 17, 2008
Registry last updated
Feb 7, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.